PL376302A1 - Nowe zastosowanie siarczanu dekstranu - Google Patents
Nowe zastosowanie siarczanu dekstranuInfo
- Publication number
- PL376302A1 PL376302A1 PL03376302A PL37630203A PL376302A1 PL 376302 A1 PL376302 A1 PL 376302A1 PL 03376302 A PL03376302 A PL 03376302A PL 37630203 A PL37630203 A PL 37630203A PL 376302 A1 PL376302 A1 PL 376302A1
- Authority
- PL
- Poland
- Prior art keywords
- dextran sulfate
- new use
- human patient
- cell transplant
- therapeutic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/721—Dextrans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/37—Digestive system
- A61K35/39—Pancreas; Islets of Langerhans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3839—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by the site of application in the body
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/54—Biologically active materials, e.g. therapeutic substances
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
- A61L2300/23—Carbohydrates
- A61L2300/232—Monosaccharides, disaccharides, polysaccharides, lipopolysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/41—Anti-inflammatory agents, e.g. NSAIDs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
- A61L2300/45—Mixtures of two or more drugs, e.g. synergistic mixtures
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
- A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
- A61L2300/64—Animal cells
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Immunology (AREA)
- Cell Biology (AREA)
- Transplantation (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Zoology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Botany (AREA)
- Gastroenterology & Hepatology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Biotechnology (AREA)
- Developmental Biology & Embryology (AREA)
- Virology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Saccharide Compounds (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0203526A SE525461C3 (sv) | 2002-11-28 | 2002-11-28 | Ny användning av dextransulfat |
Publications (2)
Publication Number | Publication Date |
---|---|
PL376302A1 true PL376302A1 (pl) | 2005-12-27 |
PL216067B1 PL216067B1 (pl) | 2014-02-28 |
Family
ID=20289705
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL376302A PL216067B1 (pl) | 2002-11-28 | 2003-11-26 | Zastosowanie siarczanu dekstranu |
Country Status (26)
Country | Link |
---|---|
US (5) | US8629123B2 (pl) |
EP (1) | EP1567171B1 (pl) |
JP (2) | JP4315908B2 (pl) |
KR (1) | KR100828807B1 (pl) |
CN (1) | CN1296051C (pl) |
AT (1) | ATE359798T1 (pl) |
AU (1) | AU2003302378B2 (pl) |
BR (1) | BRPI0316666B8 (pl) |
CA (1) | CA2507595C (pl) |
CY (1) | CY1106739T1 (pl) |
DE (1) | DE60313356T2 (pl) |
DK (1) | DK1567171T3 (pl) |
EA (1) | EA010409B1 (pl) |
ES (1) | ES2285270T3 (pl) |
HK (1) | HK1087042A1 (pl) |
HR (1) | HRP20050439B1 (pl) |
IL (1) | IL168626A (pl) |
IS (1) | IS2405B (pl) |
NO (1) | NO326946B1 (pl) |
NZ (1) | NZ540744A (pl) |
PL (1) | PL216067B1 (pl) |
PT (1) | PT1567171E (pl) |
SE (1) | SE525461C3 (pl) |
SI (1) | SI1567171T1 (pl) |
WO (1) | WO2004047848A1 (pl) |
ZA (1) | ZA200504111B (pl) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008046162A1 (en) * | 2006-10-20 | 2008-04-24 | The Australian National University | Inhibition of degradation of extracellular matrix |
WO2008153962A2 (en) * | 2007-06-08 | 2008-12-18 | The Trustees Of The University Of Pennylvania | Method of reducing tissue loss in pancreatic islet cell transplantation |
EP2550004A4 (en) * | 2010-03-12 | 2014-07-02 | Univ Australian | SUBSTITUTE THERAPY WITH HEPARAN SULFATE |
HUE044196T2 (hu) * | 2010-07-16 | 2019-10-28 | Tx Medic Ab | Sejtterápia |
CN102973592A (zh) * | 2012-11-26 | 2013-03-20 | 合肥博太医药生物技术发展有限公司 | 硫酸葡聚糖在制备治疗糖尿病药物中的应用 |
SE537742C2 (sv) * | 2013-05-13 | 2015-10-13 | Tx Medic Ab | Dextransulfat för cellmobilisering |
GB201408233D0 (en) | 2014-05-09 | 2014-06-25 | Austrianova Singapore Pte Ltd | Use of polyanionic composition |
WO2015190989A1 (en) * | 2014-06-12 | 2015-12-17 | Tx Medic Ab | The use of dextran sulfate having an average molecular weight below 10000 da for inducing angiogenisis in a subject |
KR102015197B1 (ko) * | 2014-06-12 | 2019-08-27 | 티엑스 메딕 에이비 | 대상체에서의 혈관신생을 유도하기 위한 10000Da 미만의 평균 분자량을 가지는 황산덱스트란의 용도 |
SE538503C2 (en) | 2014-11-11 | 2016-08-16 | Tx Medic Ab | New dextran sulfate |
SE539575C2 (en) * | 2015-07-30 | 2017-10-17 | Tx Medic Ab | Dextran sulfate for use in treating, inhibiting or preventing cardiac fibrosis |
JP2020533281A (ja) * | 2017-09-08 | 2020-11-19 | ティーエックス メディック エービー | デキストラン硫酸の新規使用 |
KR20230002698A (ko) * | 2020-04-15 | 2023-01-05 | 티엑스 메딕 에이비 | 패혈증 및 과다사이토카인분비증의 치료 |
SE544768C2 (en) * | 2021-03-24 | 2022-11-08 | Tx Medic Ab | Combination for treatment of thromboinflammation |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0240098A3 (en) * | 1986-04-04 | 1989-05-10 | Kabushiki Kaisha Ueno Seiyaku Oyo Kenkyujo | Oligo and polysaccharides for the treatment of diseases caused by retroviruses |
IL88554A0 (en) * | 1988-12-01 | 1989-07-31 | Hadassah Med Org | Compositions containing a compound binding to a heparin receptor |
TW318142B (pl) | 1991-06-03 | 1997-10-21 | Mitsubishi Chemicals Co Ltd | |
US5464815A (en) | 1993-09-08 | 1995-11-07 | Genentech, Inc. | Inhibition of heparin-binding |
CN1178070A (zh) * | 1996-09-27 | 1998-04-08 | 刘春江 | 组织脏器移植用保存溶液·手术等时组织脏器保护溶液 |
CN1057192C (zh) * | 1997-09-10 | 2000-10-11 | 上海长征医院 | 一种配制多器官保存液的方法 |
-
2002
- 2002-11-28 SE SE0203526A patent/SE525461C3/sv not_active IP Right Cessation
-
2003
- 2003-11-26 WO PCT/SE2003/001830 patent/WO2004047848A1/en active IP Right Grant
- 2003-11-26 BR BRPI0316666A patent/BRPI0316666B8/pt active IP Right Grant
- 2003-11-26 DE DE60313356T patent/DE60313356T2/de not_active Expired - Lifetime
- 2003-11-26 US US10/535,876 patent/US8629123B2/en active Active
- 2003-11-26 CN CNB2003801045438A patent/CN1296051C/zh not_active Expired - Lifetime
- 2003-11-26 KR KR1020057009717A patent/KR100828807B1/ko active IP Right Grant
- 2003-11-26 EA EA200500757A patent/EA010409B1/ru not_active IP Right Cessation
- 2003-11-26 CA CA2507595A patent/CA2507595C/en not_active Expired - Lifetime
- 2003-11-26 JP JP2004555208A patent/JP4315908B2/ja not_active Expired - Lifetime
- 2003-11-26 DK DK03811973T patent/DK1567171T3/da active
- 2003-11-26 PT PT03811973T patent/PT1567171E/pt unknown
- 2003-11-26 EP EP03811973A patent/EP1567171B1/en not_active Expired - Lifetime
- 2003-11-26 AT AT03811973T patent/ATE359798T1/de active
- 2003-11-26 NZ NZ540744A patent/NZ540744A/en not_active IP Right Cessation
- 2003-11-26 SI SI200330809T patent/SI1567171T1/sl unknown
- 2003-11-26 PL PL376302A patent/PL216067B1/pl unknown
- 2003-11-26 AU AU2003302378A patent/AU2003302378B2/en not_active Expired
- 2003-11-26 ES ES03811973T patent/ES2285270T3/es not_active Expired - Lifetime
-
2005
- 2005-05-17 IL IL168626A patent/IL168626A/en active IP Right Grant
- 2005-05-17 HR HR20050439A patent/HRP20050439B1/xx not_active IP Right Cessation
- 2005-05-20 ZA ZA200504111A patent/ZA200504111B/en unknown
- 2005-05-25 NO NO20052505A patent/NO326946B1/no not_active IP Right Cessation
- 2005-06-23 IS IS7908A patent/IS2405B/is unknown
-
2006
- 2006-07-03 HK HK06107463A patent/HK1087042A1/xx not_active IP Right Cessation
-
2007
- 2007-07-17 CY CY20071100954T patent/CY1106739T1/el unknown
-
2009
- 2009-03-17 JP JP2009064780A patent/JP4972113B2/ja not_active Expired - Lifetime
-
2010
- 2010-01-11 US US12/685,005 patent/US8906884B2/en active Active
-
2013
- 2013-12-06 US US14/099,518 patent/US8901104B2/en not_active Expired - Lifetime
- 2013-12-06 US US14/099,493 patent/US9364499B2/en not_active Expired - Lifetime
-
2016
- 2016-01-20 US US15/001,380 patent/US10307440B2/en not_active Expired - Lifetime
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1087042A1 (en) | New use of dextran sulfate | |
EP2277992A3 (en) | Progenitor cells from Wharton's jelly of human umbilical cord | |
AU7432796A (en) | Retrievable bioartificial implants | |
AU3155700A (en) | New biomaterials | |
NZ517772A (en) | Cytotoxic agents comprising taxanes and their therapeutic use | |
AU5647996A (en) | Artificial skin containing as support biocompatible materials based on hyaluronic acid derivatives | |
AU2003245282A1 (en) | Stent coatings with sustained drug release rate | |
NZ544009A (en) | Heteroaryl-tetrahydropiperidyl compounds useful for treating or preventing pain | |
AU3850600A (en) | Dalda analogs and their use | |
DE60327843D1 (de) | Arzneimittelformulierungen mit verzögerter freisetzung mit einem trägerpeptid | |
EP2767291A3 (en) | Treatment of glycogen storage disease type II | |
IT1307829B1 (it) | Protesi dentale con mezzi per il rilascio di farmaci o fattorispecifici atti ad impedire l'insorgenza di infezioni e/o promuovere | |
SI1546088T1 (sl) | Spojine za uporabo v zdravljenju avtoimunskih bolezni, imunoalergijskih bolezni in zavrnitve transpalantata organa ali tkiva | |
EP2364708A3 (en) | Pharmaceutical composition comprising a ClC-2 channel opener | |
HUS1900041I1 (hu) | Treoszulfán alkalmazása betegek csontvelõ- és vér õssejt-transzplantáció elõtti kondicionálására | |
AU2002952492A0 (en) | Chaperonin 10 immunosuppression | |
BR0312365A (pt) | Meio de cultura autólogo de células-mães progenitoras autólogas humanas, métodos para a preparação do mesmo e de uma composição de células-mães progenitoras autólogas humanas e para a obtenção de células-mães progenitoras musculares autólogas humanas, emprego de um meio de cultura autólogo de células-mães progenitoras autólogas humanas, procedimento para a obtenção de células-mães progenitoras musculares autólogas humanas e procedimento terapêutico de cardiomioplastia celular autóloga, composição enriquecida com células-mães progenitoras musculares autólogas humanas e composição farmacêutica | |
MXPA02005069A (es) | Agentes de enlace especificos para t3 y metodos para su uso. | |
IL131478A0 (en) | Methods for treatment of scar tissue | |
HUP0203486A2 (hu) | Véralvadással összefüggő betegségek megelőzése és kezelése | |
GEP20043231B (en) | Resorcinol Composition | |
WO1998024898A3 (en) | Therapeutic composition comprising the kal protein and use of the kal protein | |
PL361732A1 (pl) | Zastosowanie materiału biologicznego zawierającego trójwymiarowy szkielet z pochodnych kwasu hialuronowego do wytwarzania implantów w artroskopii i zestaw do przyrządów do wszczepiania takiego materiału biologicznego na drodze artroskopii | |
EP1347754A4 (en) | COMPOSITIONS FOR PREVENTION OF ADHESION | |
RU99111148A (ru) | Глазные капли |